Feven Abraha

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Phase II Evaluation Of Stereotactic Ablative Radiotherapy (SABR) in 11C-Choline PET/CT (Cho-PET)-Identified Oligometastatic Castration-Resistant Prostate Cancer (CRPC)”.

Phase II Evaluation Of Stereotactic Ablative Radiotherapy (SABR) in 11C-Choline PET/CT (Cho-PET)-Identified Oligometastatic Castration-Resistant Prostate Cancer (CRPC)

International Journal of Radiation Oncology*Biology*Physics(2020)10.1016/j.ijrobp.2020.07.429

N/A

0DataRank · unranked

0 citations

Feven Abraha, Bradley J. Stish, Val J. Lowe, Lance C. Pagliaro, C. Richard Choo +13 more

Resilient CD8 + T cells maintain a high cytotoxic capacity by balancing ROS via ME1 upregulation

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.11.25.517988

N/A

0DataRank · unranked

1 citations

Zhiming Mao, Grace DeFranco, Ying Li, Xin Liu, Jacob B. Hirdler +22 more